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Abstract
Introduction: Higher lactate concentrations within the normal reference range (relative hyperlactatemia) are not 
considered clinically significant. We tested the hypothesis that relative hyperlactatemia is independently associated 
with an increased risk of hospital death.
Methods: This observational study examined a prospectively obtained intensive care database of 7,155 consecutive 
critically ill patients admitted to the Intensive Care Units (ICUs) of four Australian university hospitals. We assessed the 
relationship between ICU admission lactate, maximal lactate and time-weighted lactate levels and hospital outcome in 
all patients and also in those patients whose lactate concentrations (admission n = 3,964, maximal n = 2,511, and time-
weighted n = 4,584) were under 2 mmol.L-1 (i.e. relative hyperlactatemia).
Results: We obtained 172,723 lactate measurements. Higher admission and time-weightedlactate concentration 
within the reference range was independently associated with increased hospital mortality (admission odds ratio (OR) 
2.1, 95% confidence interval (CI) 1.3 to 3.5, P = 0.01; time-weighted OR 3.7, 95% CI 1.9 to 7.00, P < 0.0001). This significant 
association was first detectable at lactate concentrations > 0.75 mmol.L-1. Furthermore, in patients whose lactate ever 
exceeded 2 mmol.L-1, higher time-weighted lactate remained strongly associated with higher hospital mortality (OR 
4.8, 95% CI 1.8 to 12.4, P < 0.001).
Conclusions: In critically ill patients, relative hyperlactataemia is independently associated with increased hospital 
mortality. Blood lactate concentrations > 0.75 mmol.L-1 can be used by clinicians to identify patients at higher risk of 
death. The current reference range for lactate in the critically ill may need to be re-assessed.
Introduction
In healthy individuals there is a continuous cycle of lactate
production and metabolism, which ensures that blood lac-
tate concentrations are normally low [1,2]. Higher blood
lactate concentrations occur when lactate production
exceeds clearance, when clearance capacity is decreased or
more frequently when both occur simultaneously [3,4]. Ele-
vated blood lactate concentrations above the accepted nor-
mal  reference range (absolute hyperlactataemia) are
common and associated with increased hospital mortality in
the critically ill [5-12]. Their usefulness in identifying criti-
cally ill patients at higher risk of death has led to the adop-
tion of lactate measurement in most blood gas analyzers
and the frequent measurement of lactate in the critically ill.
While the normal lactate concentration in unstressed indi-
viduals is 1.0 ± 0.5 mmol.L-1 [1,2], patients with critical ill-
ness are considered to have normal lactate levels at
concentrations of less than 2 mmol.L-1 [13]. Furthermore,
this 2 mmol.L-1 cut off may be considered to be a conserva-
tive threshold as some have suggested that a level of up to 4
mmol.L-1 is within the normal limits [14].
However, it is unknown whether a higher blood lactate
concentration within the current reference range (relative
hyperlactataemia) might also be associated with increased
hospital mortality. This knowledge would be clinically
important because the currently used upper reference limit
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for lactatemia may fail to identify many patients who are at
higher risk of death.
We hypothesized that higher blood lactate concentrations
within the reference range would be associated with an
increased risk of hospital death and investigated the rela-
tionship between ICU admission, maximal and time-
weighted blood lactate concentrations and hospital mortal-
ity in a large cohort of critically ill patients.
Materials and methods
The data collection and the data analysis for this study are
part of ongoing de-identified data auditing processes across
the participating hospitals, which have all waived the need
for informed consent. The Austin Hospital Ethics Commit-
tee approved the study.
Study population and data sources
We conducted this study as a four-centre retrospective
investigation of a prospectively gathered intensive care
database. Four Australian university teaching hospital
intensive care units enrolled patients in this study. We
included all patients admitted to these ICUs from January
2000 to October 2004.
The blood lactate concentration data used for this study
were stored and retrieved electronically. We obtained age,
sex, use of mechanical ventilation, reason for ICU admis-
sion, surgical and non-surgical divided into (trauma, car-
diac/vascular, gastrointestinal tract, neurological and
thoracic/respiratory diseases), and Acute Physiology and
Chronic Health Evaluation (APACHE) II score [15] from
the electronic data repositories of each ICU, using prospec-
tively collected data as part of a continuing data collection
by the Australian and New Zealand Intensive Care Society -
Centre for Outcome and Resources Evaluation (ANZICS-
CORE). We coded admission diagnosis by APACHE III
system used by the ANZICS-CORE - Adult Patient Data-
base [16].
All patients had initial arterial lactate and blood gas mea-
sured by blood gas analyser (Rapilab, Bayer Australia, Syd-
ney, NSW, Australia, upper normal limit 2.00 mmol.L-1) at
the time of admission to the ICU. The timing of repeat mea-
surements was at the discretion of the managing critical
care team. All subsequent blood lactate measurements were
performed using the same blood-gas analyzer in each hospi-
tal. A normal (within reference) lactate was defined as a
concentration between 0.00 and 2.00 mmol.L-1 [13]. Labo-
ratories in the participating hospitals comply with standards
of the National Association of Testing Authorities [17] and
the Royal College of Pathologists of Australasia [18].
Statistical Analysis
We used the ICU admission (LacADM) and maximal (Lac-
MAX) blood lactate concentrations to indicate the admission
and highest value recorded while in the ICU. We first
assessed blood lactate concentration in all patients and sec-
ond, in those patients whose ICU admission (LacADM), and
maximal (LacMAX) blood lactate concentrations never
exceeded the normal reference range (that is, < 2 mmol.L-
1). In addition, to avoid the potential effect of surveillance
bias due to the increased blood lactate monitoring in more
severely ill patients, we calculated the time-weighted lac-
tate concentration (LacTW). This time-weighted method is
more representative of the true lactate level during the ICU
stay than the arithmetic mean, as it assumes a linear trend
between each individual lactate measurement for each
patient during their ICU stay. This method was modified
from, and used in accordance with, an approach previously
used by Finney et al to describe hyperglycaemia [19].
As the relationship between LacADM, LacMAX, LacTW and
mortality was expected not to be linear in nature, categori-
cal variables were created. We divided lactate into four
bands: normal (0.00 to 2.00 mmol.L-1); mild hyperlactemia
(2.01 to 4.00 mmol.L-1); moderate hyperlactatemia (4.01 to
6.00 mmol.L-1) and severe hyperlactatemia (> 6.01
mmol.L-1) for comparison.
The normal range of lactate (0.00 to 2.00 mmol.L-1) was
subsequently divided into eight bands. However, due to the
small number of patients with values under < 0.75 mmol.L-
1 we combined the three lower octiles to achieve adequate
size for statistical comparison. We therefore compared: the
lower limit of normal (LLN, 0.00-0.75 mmol.L-1); upper
limit of normal (ULN, 1.76 to 2.00 mmol.L-1) and four
intermediate categories (0.75 to 1.00 mmol.L-1); (1.01 to
1.25 mmol.L-1); (1.26 to 1.50 mmol.L-1); (1.51 to 1.75
mmol.L-1).
To confirm that any association between LacTW levels
within the normal range and mortality was not being biased
by patients who had individual lactate concentrations above
2 mmol.L-1 while in the ICU, we then examined the associ-
ation between LacTW and mortality in the cohort of patients
whose lactate never exceeded 2 mmol.L-1.
The primary outcome for analysis was hospital mortality
and the secondary outcome was ICU mortality. We per-
formed crude univariate analysis with lactate as a catagorial
variable for comparison between groups according to hos-
pital survival status using chi-square test for proportions,
Student t-test for normally distributed outcomes and Wil-
coxon rank sum tests otherwise. In addition, we performed
multivariate analysis where we adjusted for all available
predictors of hospital mortality included in the models
(gender, age, APACHE II, mechanical ventilation, surgical
admission and diagnosis type) determined by backward
elimination of non-significant variables. Furthermore, to
determine if the lactate associations were consistent across
patient admission diagnosis subgroups and study hospitals,
we examined the interactions between measures of lactateNichol et al. Critical Care 2010, 14:R25
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and other variables in the model. We report results from the
multivariate models using odds ratios, OR (95% confidence
intervals, 95% CI).
All analyses were performed using SAS version 9.2 (SAS
Institute Inc, Cary, NC, USA). A two-sided P-value of 0.05
was considered to be statistically significant.
Results
We studied a heterogeneous cohort of 7,155 critically ill
patients with 172,723 blood lactate measurements (Table
1). The absolute blood lactate concentrations (admission
lactate LacADM, maximal lactate LacMAX and time-weighted
lactate LacTW), were significantly higher in non-survivors
compared to survivors (Table 1).
Overall assessment of hyperlactatemia (absolute 
hyperlactatemia)
A higher crude LacADM, LacMAX and LacTW concentration
above the reference range (0.00 to 2.00 mmol.L-1) was
associated with a higher hospital and ICU mortality rate
(Figure 1, Panel a, b, c, respectively). Multivariate analysis
showed that compared to the current reference lactate con-
centration (0.00 to 2.00 mmol.L-1) a higher LacADM (> 8
mmol.L-1), LacMAX  (> 10 mmol.L-1) and LacTW  (> 6
mmol.L-1) blood lactate concentration was strongly associ-
ated with an increased adjusted hospital mortality (LacADM
OR213.49 (95% CI 28.69 to 1588.71), P < 0.0001); LacMAX
OR8.44 (95% CI 5.99 to 11.91), P < 0.0001) LacTW OR
37.78 (95% CI 18.72 to 76.25), P < 0.0001). This associa-
tion between lactate (LacADM, LacMAX  and LacTW) and
adjusted mortality was independent of admission diagnosis,
admission hospital and APACHE II score.
Assessment of relative hyperlactatemia
We further identified the cohorts of patients with a LacADM
(n = 3,964), LacMAX, (n = 2,511) and with LacTW (n =
4,584) within the current reference range (0.00 to 2.00
mmol.L-1). Table 2 shows the clinical characteristics of the
LacADM subgroup of patients divided into hospital survivors
and non-survivors. Patients with an admission or time
weighted lactate level just below 2 mmol.L-1 had a crude
hospital mortality rate of approximately 20% (Figures 2a
and 3b). LacADM, LacMAX and LacTW  were significantly
higher in hospital non-survivors compared to survivors
(Table 2).
A higher admission lactate (LacADM) concentration
within the reference range was associated with higher crude
hospital mortality (Figure 2a), with a mortality rate of
18.5% in the higher risk cohort. There also was a significant
independent relationship between LacADM within the refer-
ence range and adjusted hospital mortality (Figure 2b).
Higher LacTW within the reference range was independently
associated with higher adjusted hospital mortality (Figure
3b) with a crude mortality rate of 21.1% in the higher risk
cohort (Figure 3a). In addition, higher LacTW (1.5 to 2.00
mmol.L-1 vs 0.00 to 0.75 mmol.L-1) was also independently
associated with hospital mortality in the cohort of patients
whose lactate never exceeded 2 mmol.L-1 (LacTW OR4.8,
95% CI 1.8 to 12.4, P < 0.001, n = 2,254).
The association between adjusted hospital mortality and
LacADM and LacTW lactate concentrations within the normal
range was first detected at lactate concentrations over 0.75
mmol.L-1 and the strength of this association increased with
higher lactate concentrations within the reference range
(Figures 2b and 3b). The detected association between lac-
tate within the reference range and adjusted hospital mortal-
ity was independent of admission diagnosis, admission
hospital and APACHE II score. Interestingly, a higher crude
and adjusted maximal lactate (LacMAX) concentration
within the normal reference range was not independently
associated with increased hospital mortality (data not
shown).
Discussion
Statement of key findings
We tested whether higher levels of lactatemia within the
current reference range (relative hyperlactemia) are inde-
pendently associated with an increased risk of hospital mor-
tality. We found that most patients admitted to ICU had an
admission or time weighted lactate level within the current
normal reference range and yet a crude hospital mortality
rate of approximately 20%. We also found that higher ICU
admission (LacADM) and time weighted (LacTW) blood lac-
tate concentrations within the normal reference range were
strongly and independently associated with hospital mortal-
ity. In addition, this increased mortality risk was first
detected at lactate concentrations above 0.75 mmol.L-1.
Comparison with previous studies
Many studies have found that either LacADM or LacMAX
above the reference range are associated with higher mor-
tality following cardiothoracic surgery [12], trauma [7],
major abdominal surgery [5], high risk surgery, major vas-
cular trauma, sepsis [20], liver disease [21], in ventilated
neonates [22] and critically ill children [11]. Our observa-
tions that the extent of absolute hyperlactatemia is strongly
linked with mortality independent of admission diagnostic
group in a large mixed cohort of critically ill patients con-
firm that lactate is a useful marker in the intensive care set-
ting to identify patients at high risk of death. In addition,
these findings suggest that other observations related to lac-
tate obtained from our cohort might also be generalizable.
In addition, we found that time weighted lactate (LacTW), a
representation of the lactate concentration throughout the
ICU stay, was strongly associated with increasing hospitalNichol et al. Critical Care 2010, 14:R25
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mortality. The finding that the duration of this derangement
while in the ICU is associated with increased mortality
expands previous work demonstrating that periods of sus-
tained hyperlactataemia (that is, ongoing excess production
or decreased clearance of lactate) is associated with an
increased risk of death [3,5,23-28].
To our knowledge, this is the first study to assess the rela-
tionship of higher lactate concentrations within the current
reference range and mortality. We found a strong associa-
tion between an increased LacADM and LacTW within the
current reference range and increased hospital mortality.
Furthermore, we demonstrated that higher LacTW in the
cohort of patients whose lactate ever exceeded 2 mmol.L-1
was also strongly associated with higher hospital mortality.
These results suggest that relative hyperlactaemia may be
useful in identifying critically ill patients at high risk of
death. Furthermore, we have demonstrated that the higher
mortality associated with higher lactate levels (LacADM and
LacTW) within the normal reference range is detectable at
all concentrations > 0.75 mmol.L-1 compared to 0.00 to
0.75 mmol.L-1. In their aggregate, these results suggest that
the transition from physiological to pathological lactatemia
occurs at a concentration well below 2.00 mmol.L-1 and that
an elevated LacADM and/or LacTW > 0.75 mmol.L-1 identi-
fies critically ill patients at higher risk of death.
Implications for clinicians
These findings expand our understanding of lactate as a
clinical biomarker in the ICU. Relatively small changes in
lactate homeostasis as detected by higher blood concentra-
tions within the reference range may reflect important oth-
erwise undetected physiological changes, which may reflect
widespread metabolic stress [29] and increased use of lac-
tate as a fuel source [30].
A higher time weighted lactate (LacTW) below 2 mmol.L-
1, the cohort of patients whose lactate ever exceeded 2
mmol.L-1, was also strongly associated with increased hos-
pital mortality. This finding extends our understanding of
the reference range by emphasizing the role of the duration
of lactate derangement in predicting increased risk of death
Table 1: Clinical characteristics of hospital survivors and non-survivors
nH o s p i t a l
Non-survivors
nH o s p i t a l  
Survivors
P-value
Male Sex 1,561 57.3% (894) 5,590 60.2% (3,365) 0.035
APACHE II score 1,250 24.6 (8.1) 4,845 15.1 (6.6) < 0.0001
Age (yr) 1,428 65.8 (16.6) 5,181 59.7 (18.9) < 0.0001
Number on mechanical 
ventilation
1,434 81.2% (1164) 5,515 55.6% (3,066) < 0.0001
Surgical patients 1,565 28.4% (444) 5,590 48.7% (2,722) < 0.0001
Diagnosis at admission
Cardiac and vascular 1,565 26% (407) 5,590 21.6% (1,207) 0.0003
Thoracic and respiratory 1,565 18.5% (290) 5,590 18.9% (1,057) 0.69
Trauma 1,565 2.2% (34) 5,590 7.9% (442) < 0.0001
Neurological 1,565 14.1% (221) 5,590 10.9% (609) 0.0004
Gastrointestinal tract 
diseases
1,565 14.1% (221) 5,590 22.9% (1,280) < 0.0001
Other 1,565 25% (391) 5,590 17.7% (989) < 0.0001
ICU stay (days) 1,559 3.0 (1.5 to 6.6) 5,589 2.5 (1.6 to 4.9) < 0.0001
Hospital stay (days) 1,312 9 (3 to 24) 5,131 14 (8 to 29) < 0.0001
Admission blood lactate
(mmom.L-1)
1,395 2.3 (1.4 to 4.4) 5,037 1.5 (1.0 to 2.4) < 0.0001
Time-weighted blood lactate
(mmom.L-1)
1,411 2.0 (1.4 to 3.3) 4,977 1.3 (1.0 to 1.8 < 0.0001
Max blood lactate (mmom.L-1) 1,565 4.0 (2.2 to 7.5) 5,590 2.1 (1.4 to 3.3) < 0.0001
Data are expressed as, percentage (number), (standard deviation) or median (interquartile range).
APACHE II, Acute Physiology and Chronic Health Evaluation II.Nichol et al. Critical Care 2010, 14:R25
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[3,5,23-25,28,31,32]. Furthermore, it highlights the clinical
importance of persistently higher lactate concentrations.
This notion may explain why LacTW (which reflects the
extent and duration of the derangement) but not LacMAX
(which only reflects its momentary extent) predicted mor-
tality within the reference range.
Our results suggest that ICU clinicians confronted with a
patient with a LacADM or LacTW (persistently higher lactate)
over 0.75 mmol.L-1 should look for any remediable causes
of physiological stress and appreciate that these patients are
at increased risk of an adverse outcome.
Strengths and limitations of the study
The strengths of our study include the fact that it is the larg-
est investigation of lactatemia in a general multicenter
cohort of patients, thus carrying a higher degree of external
validity. It used data from > 170,000 measurements
obtained with state-of the-art technology, thus increasing
their accuracy and reproducibility. It used robust and clini-
cally relevant outcomes. It is the first to study the indepen-
dent relationship between relative hyperlactatemia and
outcome and identified clinically relevant findings. Limita-
tions of the study include the fact that it is retrospective in
design and thus potentially subject to systematic error and
bias. However, all the clinical and electronic data utilised
were collected prospectively in a large number of consecu-
tive critically ill patients in four ICUs. The data are numeri-
cal in nature and were measured independently; thus they
were not amenable to selection bias or unintended manipu-
lation. A number of common ICU therapeutic interventions
such as epinephrine [33], metformin [34], nucleoside ana-
logues in HIV [35], high-volume hemofiltration (HVHF)
with lactate-buffered replacement fluids [36] can all affect
lactate levels and we did not have information on their use.
We were therefore unable to include these in our multivari-
ate analyses. However, the size of our study and the
strength of the association between LacADM and LacTW and
mortality within the reference range independent of admis-
sion diagnosis and hospital suggest that these factors are not
likely to have confounded the signal in this study. Despite
this, clinicians should be aware of the potential of these iat-
rogenic causes of relative or absolute hyperlactataemia.
Due to the smaller numbers of patients in the cohort with
LacADM and LacTW in the lowest three octiles, we com-
Figure 1 Relationship among the admission, maximal and time weighted blood lactate concentration and mortality. Relationship among the 
admission blood lactate concentration (LacADM) Panel (a); maximal blood lactate concentration (LacMAX;) Panel (b); and time weighted blood lactate 
concentration (LacTW) Panel (c); and hospital and ICU mortality. The number of patients in each group is expressed as (n).Nichol et al. Critical Care 2010, 14:R25
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Figure 2 Relationship between the admission blood lactate concentration within the normal range and mortality rate. Relationship between 
the admission blood lactate (LacADM) concentration within the normal range and ICU and hospital mortality rate (Panel (a)). The number of patients 
in each group is expressed as (n). Panel (b) displays the result (adjusted odds ratios (OR) with 95% Confidence Interval (CI)) of a multivariate analysis 
assessing the association between admission blood lactate (LacADM) within the normal range and hospital mortality. (All ORs in the multivariate anal-
ysis are compared to the 0.00 to 0.75mmol.L-1 group with the horizontal line representing an OR of 1.0.).
pressed these octiles into a single group (0.00 to 0.75
mmol.L-1) to provide sufficient numbers for statistical anal-
yses. This compression limited our ability to determine if
higher blood lactate concentrations below 0.75 mmol.L-1
may also be associated with increasing mortality.
Future research
Our findings are novel and need to be confirmed by similar
studies in other countries or patient populations before they
can be considered to reflect a general biological principle.
Such studies should ideally be performed prospectively
with a simultaneous collection of information on interven-
tions, which may affect lactate by dilution (intravenous flu-
ids) or by changing its metabolism (drugs) and these studies
should ideally also include non-ICU cohorts of patients
(that is, Emergency Department patients). If these studies
confirm the value of relative hyperlactatemia, the reference
value for lactate in critically ill patients may require adjust-
ment.
Conclusions
In conclusion, higher LacADM and LacTW blood lactate con-
centrations within the current reference range are associated
with greater hospital mortality. These results suggest thatNichol et al. Critical Care 2010, 14:R25
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Figure 3 Relationship between time-weighted blood lactate concentration within the normal range and mortality rate. Relationship be-
tween time-weighted blood lactate (LacTW) concentration within the reference range and ICU and hospital mortality rate (Panel (a)). The number of 
patients in each group is expressed as (n). Panel (b) displays the result (adjusted odds ratios (OR) with 95% Confidence Interval (CI)) of a multivariate 
analysis assessing the association between time-weighted blood lactate concentration (LacTW) within the normal range and hospital mortality. Abbre-
viations: OR U95; odds ratio upper 95% CI; OR L95, odds ratios lower 95% CI. (All ORs in the multivariate analysis are compared to 0.00 to 0.75 mmol.L-
1 group with the horizontal line representing an OR of 1.0.).
even relative hyperlactaemia is a useful biomarker in criti-
cal illness. They also suggest that the upper level of the ref-
erence value for lactate in critically ill patients may require
readjustment. Finally, they imply that clinicians should be
especially alert in all patients with admission and/or persis-
tent blood lactate concentrations within the current upper
limit of the reference range.
Key messages
• Blood lactate concentration is increasingly being mea-
sured in the critically ill.
• Higher intensive care unit blood lactate concentrations
above the current normal  range (absolute hyperlac-
tatemia) are associated with increased hospital mortal-
ity.
• Higher intensive care unit admission blood lactate
concentrations within the current normal range (relativeNichol et al. Critical Care 2010, 14:R25
http://ccforum.com/content/14/1/R25
Page 8 of 9
Table 2: Clinical characteristics for hospital survivors and non-survivors in patients with admission blood lactate 
concentration within the reference range
nH o s p i t a l  
Non-survivors
nH o s p i t a l  
Survivors
P-value
Male Sex 607 58.2% (353) 3,357 59% (1,981) 0.71
APACHE II score 485 22.1 (7.3) 2,891 14.2 (6.2) < 0.0001
Age (yr) 556 66.0 (16.5) 3,090 60.7 (18.7) < 0.0001
Number on mechanical ventilation 551 77.3% (426) 3,313 48.7% (1,613) < 0.0001
Surgical patients 607 31% (188) 3,357 50.9% (1,709) < 0.0001
Diagnosis at admission
Cardiac and vascular 607 15.2% (92) 3,357 20.4% (685) 0.003
Thoracic and respiratory 607 24.2% (147) 3,357 20% (671) 0.017
Trauma 607 3.6% (22) 3,357 8.8% (295) < 0.0001
Neurological 607 18.1% (110) 3,357 10.9% (366) < 0.0001
Gastrointestinal tract diseases 607 15.3% (93) 3,357 23.7% (796) < 0.0001
Other 607 23.6% (143) 3,357 16.2% (544) < 0.0001
ICU stay (days) 606 3.0 (2.0 to 8.0) 3,357 2.0 (1.3 to 4.0) < 0.0001
Hospital stay (days) 501 12.9 (5.2 to 30.2) 3,064 13.0 (7.9 to 26.7) 0.041
Admission blood lactate (mmom.L-1) 607 1.3 (1 to 1.6) 3,357 1.2 (0.9 to 1.5) < 0.0001
Time-weighted blood lactate
(mmom.L-1)
599 1.4 (1.1 to 1.9) 3,212 1.20 (1.0 to 1.5) < 0.0001
Max blood lactate (mmom.L-1) 607 2.4 (1.6 to 4.1) 3,357 1.7 (1.3 to 2.4) < 0.0001
Data are expressed as, percentage (number), (standard deviation) or median (interquartile range) APACHE II, Acute Physiology and Chronic 
Health Evaluation II.
hyperlactatemia) are associated with increased hospital
mortality.
• Higher time weighted intensive care unit blood lactate
concentrations within the current normal range (relative
hyperlactatemia) are associated with increased hospital
mortality.
• Higher blood lactate concentrations within the current
normal range can be used to identify patients at high
risk of death; possibly suggesting that we need to revise
the current definition of normal blood lactate concentra-
tion in the critically ill.
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